Welcome, we're excited to share our patented WoundGelHA!
Hi, we are MAGNA Pharmaceuticals! We are excited to introduce you to our patented WoundGelHA (WGHA)! WGHA is formulated to provide wound care dressing & management. WGHA is a combination of emollients & sodium hyaluronate, which function to maintain tissue hydration & support the healing process. WGHA has been demonstrated to be of value in the management of certain skin ulcers. Sodium hyaluronate is a salt of hyaluronic acid, a naturally occurring molecule found in various body tissues. The sodium hyaluronate present in WGHA is derived from synthetic sources. WGHA [(based on FDA 510(k) K143527)] is indicated for management of exudating wounds such as leg ulcers, pressure ulcers, diabetic ulcers, surgical wounds (post-operative incisions and donor cites), mechanically or surgically debrided wounds, and for second degree burns. WGHA should be applied after the ulcer/wound is cleaned with normal saline solution. Excess moisture should be remoced using dry gauze. WGHA is applied liberally into the ulcer/wound & surrounding area. A non-stick gauze should then be applied and covered with an occlusive dressing.